3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Other neoplasm
1
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
16
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Ovarian Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
6
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Sirolimus
2
Riluzole
2
Oncolytic Virotherapy
2
Ipilimumab
2
Blood Specimen Collection
2
vofatamab
1
tocilizumab
1
saracatinib
1
poly ICLC
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fludarabine phosphate
1
enzalutamide
1
durvalumab
1
cediranib
1
brodalumab
1
atezolizumab
1
aldesleukin
1
advexin
1
Ultrasonography
1
Tissue Banks
1
TKM-080301
1
Ritonavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Mass Spectrometry
×
Breast
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled